Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03277261
Brief Title: A Phase 3, Randomized, Multi-center, Double-blinded, Active-controlled Study to Assess the Efficacy and Safety/Tolerability of Ublituximab (TG-1101; UTX) as Compared to Teriflunomide in Subjects With Relapsing Multiple Sclerosis (RMS) (ULTIMATE 1)

First Submitted : September 7, 2017
First Submitted that Met QC Criteria : September 7, 2017
First Posted : September 11, 2017

Certification/Extension First Submitted : May 11, 2021
Certification/Extension First Submitted that Met QC Criteria : May 11, 2021
Certification/Extension First Posted : May 20, 2021

Last Update Submitted that Met QC Criteria : May 11, 2021
Last Update Posted : May 20, 2021